Related Experiment Videos
Are racial differences in antihypertensive responsiveness reflected in usage after stroke?
Bruce Ovbiagele1, Nancy K Hills, Jeffrey L Saver
1Stroke Center and Department of Neurology, University of California at Los Angeles Medical Center, Los Angeles, California, USA.
Insights
Black patients hospitalized for ischemic stroke received similar antihypertensive prescriptions compared to other races. This study found no differences in discharge medication patterns, despite known variations in drug response.
Area of Science:
- Clinical Neurology
- Cardiovascular Medicine
- Pharmacology
Background:
- Differential antihypertensive drug responses are documented in Black populations.
- Understanding prescription patterns is crucial for optimizing stroke care.
- Ischemic cerebrovascular events require effective post-hospitalization management.
Purpose of the Study:
- To investigate if racial disparities in antihypertensive effectiveness are reflected in discharge medication practices.
- To compare antihypertensive prescription rates in Black patients versus other races following ischemic stroke hospitalization.
Main Methods:
- Analysis of discharge antihypertensive medication use from the California Acute Stroke Prototype Registry.
- Comparison of prescription rates between Black patients and all other races combined.
- Use of generalized estimating equations to identify factors associated with medication receipt.
Main Results:
- No significant differences in overall antihypertensive use were observed between Black patients (74%) and other races (69%).
- Specific categories of antihypertensives showed no significant disparity in prescription rates.
- A non-significant trend indicated more frequent diuretic use in Black patients (P = .12).
Conclusions:
- Discharge antihypertensive prescription patterns did not differ between Black patients and other races hospitalized with ischemic stroke or transient ischemic attack.
- Current prescribing practices may not account for known differential responses to antihypertensives in Black individuals.
- Further research is needed to align treatment strategies with observed pharmacological differences.
Objective:
We sought to evaluate whether differential antihypertensive responsiveness in blacks is reflected in discharge antihypertensive prescription patterns among patients hospitalized with an ischemic cerebrovascular event.
Methods:
We analyzed use of discharge antihypertensive medications among patients hospitalized with an ischemic cerebrovascular event in the California Acute Stroke Prototype Registry, examining rates in black patients compared with all other races combined. Generalized estimating equations were used to identify factors independently associated with receipt of any antihypertensive medication overall and with use of specific types of antihypertensives.
Results:
Data were collected on 794 consecutive patients treated at 11 hospitals. No significant differences were observed between rates of antihypertensive use in black patients (74%) when compared with all others (69%), either for overall use or for any specific category of antihypertensive, although there was a trend toward more frequent use of diuretics in black patients (P = .12). Results were similar when analysis was limited to those with a history of hypertension.
Conclusions:
In spite of a known differential response to antihypertensives in blacks, we found no differences in discharge antihypertensive prescription patterns in black patients hospitalized with transient ischemic attack and ischemic stroke compared with other races.
Related Concept Videos
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Drug Toxicity: Risk factors
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacodynamics in Geriatric Patients: Effects of Age
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System